Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CREB1 and GSK3 Isoforms as Potential Adaptive Signaling Nodes in PI3K/Akt/mTOR Inhibitor Treated Philadelphia Chromosome-Positive B-ALL. | Int J Mol Sci | 2026 | 42794727 | PubTator, text mining | PubMed |
| Deep learning-assisted virtual screening of a large chemical library for selective GSK3β inhibitors. | Mol Divers | 2026 | 42584522 | PubTator, text mining | PubMed |
| Navigating the Complexity: A Comprehensive Review of GSK-3 Inhibition in Regenerative Medicine. | Med Res Rev | 2026 | 42559793 | PubTator, text mining | PubMed |
| A universal 6iL/E4 culture system for deriving and maintaining embryonic stem cells across mammalian species. | Cell Res | 2026 | 42443522 | PubTator, text mining | PubMed |
| Integrated Proteomic and Phosphoproteomic Profiling Reveals Mechanisms of Bisphenol A Induced Placental Toxicity. | Chem Res Toxicol | 2026 | 42440269 | PubTator, text mining | PubMed |
| Integrated machine learning, molecular docking, and molecular dynamics simulations for in silico identification of GSK3β inhibitors for Alzheimer's disease. | Sci Rep | 2026 | 42365084 | PubTator, text mining | PubMed |
| Rosmarinic acid as a potential GSK3β inhibitor for autism spectrum disorder: insights from an integrative in silico study. | In Silico Pharmacol | 2026 | 42064451 | PubTator, text mining | PubMed |
| Dual-target antioxidant potential of benzimidazole-based thiazine and N-tosylated analogues: computational insights into human 11β-HSD1 and Leishmania GSK-3α inhibition. | Comput Biol Med | 2026 | 42061289 | PubTator, text mining | PubMed |
| GSK3α functions as a stemness checkpoint across multiple stem cell states. | Cell Res | 2026 | 41951855 | PubTator, text mining | PubMed |
| Wnt-dependent Frizzled clustering is required for Dishevelled phosphorylation but insufficient for β-catenin stabilization. | Sci Signal | 2026 | 41945658 | PubTator, text mining | PubMed |
| FASLG Derived from Fibroblasts in Hydroxyapatite-Rich Microenvironment Induces Urothelial Anoikis to Trigger Randall's Plaque Exposure. | Adv Sci (Weinh) | 2026 | 41926645 | PubTator, text mining | PubMed |
| GSK3β as a potential regulator in AML: A pan-cancer multi-omics analysis. | PLoS One | 2026 | 41915675 | PubTator, text mining | PubMed |
| A Single Bout of Aerobic Exercise Increases Neuronal Extracellular Vesicle-Derived Insulin Signaling Biomarkers in Adults With Cardiometabolic Risk. | Compr Physiol | 2026 | 41876945 | PubTator, text mining | PubMed |
| Molecular mechanisms of exercise-induced improvements in Alzheimer's disease: a focus on lipid homeostasis. | Transl Neurodegener | 2026 | 41866584 | PubTator, text mining | PubMed |
| Spatio-temporal dynamics of autophagy-associated genes in macrophage-driven atherosclerosis: an integrated omics and experimental study. | Front Endocrinol (Lausanne) | 2026 | 41837135 | PubTator, text mining | PubMed |
| GSK-3α activation mitigates Doxorubicin-induced cardiomyopathy through Keap1/Nrf2/HO-1 axis. | Life Sci | 2026 | 41812974 | PubTator, text mining | PubMed |
| Dental microplastics as emerging neurotoxicants: a systematic review on human data. | PeerJ | 2026 | 41773189 | PubTator, text mining | PubMed |
| Spatial phosphoproteomics reveals regional phosphorylation features in liver cirrhosis progression. | J Transl Med | 2026 | 41764534 | PubTator, text mining | PubMed |
| Erratum for the Research Article "IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages" by X. Wang et al. | Sci Adv | 2026 | 41758958 | PubTator, text mining | PubMed |
| The Molecular Network of Neutrophil Extracellular Traps in Hepatocellular Carcinoma: Biogenesis, Function, and Therapeutic Implications. | Molecules | 2026 | 41752527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers